Biotage AB (BIOT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Biotage AB (BIOT) has a cash flow conversion efficiency ratio of 0.011x as of March 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr43.00 Million ≈ $4.63 Million USD) by net assets (Skr3.85 Billion ≈ $413.89 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Biotage AB - Cash Flow Conversion Efficiency Trend (2002–2024)
This chart illustrates how Biotage AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read BIOT total debt and obligations for a breakdown of total debt and financial obligations.
Biotage AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Biotage AB ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Treehouse Foods Inc
NYSE:THS
|
0.030x |
|
Suzhou Chunqiu Electronic Technology Co Ltd Class A
SHG:603890
|
0.028x |
|
INKON Life Technology Co Ltd
SHE:300143
|
0.028x |
|
Under Armour Inc C
NYSE:UA
|
0.194x |
|
Henan Yicheng New Energy Co Ltd
SHE:300080
|
-0.017x |
|
GMP Property SOCIMI SA
MC:YGMP
|
0.013x |
|
Tourmaline Bio Inc.
NASDAQ:TRML
|
-0.078x |
|
Grupo Herdez S.A.B. de C.V
MX:HERDEZ
|
0.020x |
Annual Cash Flow Conversion Efficiency for Biotage AB (2002–2024)
The table below shows the annual cash flow conversion efficiency of Biotage AB from 2002 to 2024. For the full company profile with market capitalisation and key ratios, see BIOT company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Skr4.11 Billion ≈ $442.62 Million |
Skr413.00 Million ≈ $44.45 Million |
0.100x | +29.30% |
| 2023-12-31 | Skr3.66 Billion ≈ $393.55 Million |
Skr284.00 Million ≈ $30.56 Million |
0.078x | -62.72% |
| 2022-12-31 | Skr1.64 Billion ≈ $176.17 Million |
Skr341.00 Million ≈ $36.70 Million |
0.208x | -19.04% |
| 2021-12-31 | Skr1.37 Billion ≈ $147.65 Million |
Skr353.00 Million ≈ $37.99 Million |
0.257x | -8.72% |
| 2020-12-31 | Skr990.04 Million ≈ $106.54 Million |
Skr279.05 Million ≈ $30.03 Million |
0.282x | +16.50% |
| 2019-12-31 | Skr875.50 Million ≈ $94.22 Million |
Skr211.81 Million ≈ $22.79 Million |
0.242x | +9.59% |
| 2018-12-31 | Skr702.18 Million ≈ $75.57 Million |
Skr155.00 Million ≈ $16.68 Million |
0.221x | -20.47% |
| 2017-12-31 | Skr608.61 Million ≈ $65.50 Million |
Skr168.93 Million ≈ $18.18 Million |
0.278x | +12.42% |
| 2016-12-31 | Skr563.24 Million ≈ $60.61 Million |
Skr139.07 Million ≈ $14.97 Million |
0.247x | +12.41% |
| 2015-12-31 | Skr546.66 Million ≈ $58.83 Million |
Skr120.08 Million ≈ $12.92 Million |
0.220x | +36.47% |
| 2014-12-31 | Skr502.65 Million ≈ $54.09 Million |
Skr80.91 Million ≈ $8.71 Million |
0.161x | +35.21% |
| 2013-12-31 | Skr476.77 Million ≈ $51.31 Million |
Skr56.76 Million ≈ $6.11 Million |
0.119x | -15.15% |
| 2012-12-31 | Skr530.83 Million ≈ $57.13 Million |
Skr74.47 Million ≈ $8.01 Million |
0.140x | -27.45% |
| 2011-12-31 | Skr563.90 Million ≈ $60.68 Million |
Skr109.05 Million ≈ $11.74 Million |
0.193x | +90.70% |
| 2010-12-31 | Skr567.95 Million ≈ $61.12 Million |
Skr57.59 Million ≈ $6.20 Million |
0.101x | +204.67% |
| 2009-12-31 | Skr1.09 Billion ≈ $117.20 Million |
Skr36.25 Million ≈ $3.90 Million |
0.033x | -57.81% |
| 2008-12-31 | Skr1.12 Billion ≈ $121.05 Million |
Skr88.74 Million ≈ $9.55 Million |
0.079x | +86.31% |
| 2007-12-31 | Skr796.26 Million ≈ $85.69 Million |
Skr33.72 Million ≈ $3.63 Million |
0.042x | -24.40% |
| 2006-12-31 | Skr712.47 Million ≈ $76.67 Million |
Skr39.91 Million ≈ $4.29 Million |
0.056x | +303.79% |
| 2005-12-31 | Skr738.25 Million ≈ $79.45 Million |
Skr-20.29 Million ≈ $-2.18 Million |
-0.027x | +85.31% |
| 2004-12-31 | Skr523.13 Million ≈ $56.30 Million |
Skr-97.89 Million ≈ $-10.53 Million |
-0.187x | -13.75% |
| 2003-12-31 | Skr609.50 Million ≈ $65.59 Million |
Skr-100.27 Million ≈ $-10.79 Million |
-0.165x | +20.20% |
| 2002-12-31 | Skr616.16 Million ≈ $66.31 Million |
Skr-127.02 Million ≈ $-13.67 Million |
-0.206x | -- |
About Biotage AB
Biotage AB (publ) provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, parallel peptide purification, and work-up products; flash systems and accessories, and normal and reversed phase cartridges; sample preparation produ… Read more